Search results for:
topiramate
topiramate
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-formulary |
Interchange |
| Topamax Sprinkle |
CAPSULE |
15 mg |
|
|
|
|
| Topamax Sprinkle |
CAPSULE |
25 mg |
|
|
|
|
| Topamax |
TABLET |
25 mg |
|
|
|
|
| Topamax |
TABLET |
100 mg |
|
|
|
|
| Epronita |
SOLUTION, ORAL |
25 mg/ml |
|
|
|
|
| Topamax |
SUSPENSION |
20 mg/ml (Rx Compound) |
|
|
|
|
Last updated: Dec. 22, 2021
The pharmacy compounded oral suspension is RESTRICTED to use only during shortages of the commercially available topiramate oral solution. Please note the concentration difference.
Note: A topiramate solution (25 mg/mL) for oral administration is commercially available.
20 mg/mL Oral Suspension (ASHP Standard Concentration) (ASHP 2017)
A 20 mg/mL oral suspension may be made with topiramate tablets or powder, Ora-Plus and Ora-Sweet. Measure out 2,000 mg of topiramate (equivalent tablets or powder). If using tablets, crush in a mortar and reduce to a fine powder. Add 10 mL of Ora-Plus and mix to a uniform paste; mix while adding an additional 40 mL of Ora-Plus in incremental proportions. Add a small amount of Ora-Sweet and mix. Transfer to a calibrated, amber bottle; rinse mortar with Ora-Sweet and add sufficient quantity to make 100 mL. Label "shake well." Stable for 90 days refrigerated or at room temperature (Allen 2017).
Allen LV Jr. Contemporary compounding: topiramate 20 mg/mL oral suspension. U.S. Pharmacist. 2017;42(5):46-47.